Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

International Journal of Antimicrobial Agents

Volumn 44, Issue 6, 2014, Pages 528-532

  Spanakis, Nikolaos ^a   Tsiodras, Sotirios ^a,b   Haagmans, Bart L ^c   Raj, V Stalin ^c   Pontikis, Kostantinos ^a   Koutsoukou, Antonia ^a   Koulouris, Nikolaos G ^a   Osterhaus, Albert D M E ^c   Koopmans, Marion P G ^c   Tsakris, Athanassios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hellenic Centre for Disease Control and Prevention   (Greece)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antiviral treatment; Coronavirus; MERS; MERS CoV; Phylogeny; Serology

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LOPINAVIR PLUS RITONAVIR; PEGINTERFERON; RIBAVIRIN; ANTIVIRUS AGENT; DRUG COMBINATION; LOPINAVIR; LOPINAVIR-RITONAVIR DRUG COMBINATION; RITONAVIR;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; COLON ADENOCARCINOMA; COMBINATION CHEMOTHERAPY; CONSTIPATION; CORONAVIRUS INFECTION; DEATH; DIARRHEA; DRUG WITHDRAWAL; FEVER; GENETIC STABILITY; GREECE; HUMAN; HYPERBILIRUBINEMIA; HYPERCAPNIA; HYPOXIA; INTUBATION; JAUNDICE; KIDNEY FAILURE; LOADING DRUG DOSE; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; NONHUMAN; PHYLOGENY; SAUDI ARABIA; SEPTIC SHOCK; SEROCONVERSION; VIREMIA; VIRUS EXCRETION; VIRUS NEUTRALIZATION; VIRUS SHEDDING; VIRUS STRAIN; COMBINATION DRUG THERAPY; CORONAVIRUS INFECTIONS; DRUG COMBINATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RESPIRATORY TRACT INFECTIONS; VIROLOGY;

ANTIVIRAL AGENTS; CORONAVIRUS INFECTIONS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; GREECE; HUMANS; LOPINAVIR; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PHYLOGENY; RESPIRATORY TRACT INFECTIONS; RIBAVIRIN; RITONAVIR; VIREMIA; VIRUS SHEDDING;

EID: 84911945010     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.07.026     Document Type: Article

References (30)

1. European Centre for Disease Prevention and Control Epidemiological update: Middle East respiratory syndrome coronavirus (MERS-CoV) 2 July 2014 ECDC http://www.ecdc.europa.eu/en/press/news/-layouts/forms/News-DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=1029 [accessed 9 September 2014]
2. J.A. Al-Tawfiq, and Z.A. Memish What are our pharmacotherapeutic options for MERS-CoV? Expert Rev Clin Pharmacol 7 2014 235 238
3. J.A. Al-Tawfiq, H. Momattin, J. Dib, and Z.A. Memish Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study Int J Infect Dis 20 2014 42 46
4. H. Momattin, K. Mohammed, A. Zumla, Z.A. Memish, and J.A. Al-Tawfiq Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy Int J Infect Dis 17 2013 e792 e798
5. Clinical Decision Making Tool for Treatment of MERS-CoV v.1.1, 29 July, 2013. Public Health England. http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317139281416 [accessed 11 September 2014].
6. S. Tsiodras, A. Baka, A. Mentis, D. Iliopoulos, X. Dedoukou, and G. Papamavrou A case of imported Middle East respiratory syndrome coronavirus infection and public health response, Greece, April 2014 Euro Surveill 19 2014 20782
7. V.M. Corman, M.A. Müller, U. Costabel, J. Timm, T. Binger, and B. Meyer Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections Euro Surveill 17 2012 pii: 20334
8. V.M. Corman, I. Eckerle, T. Bleicker, A. Zaki, O. Landt, and M. Eschbach-Bludau Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction Euro Surveill 17 2012 pii: 20285
9. C.B. Reusken, B.L. Haagmans, M.A. Müller, C. Gutierrez, G.J. Godeke, and B. Meyer Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study Lancet Infect Dis 13 2013 859 866
10. B.L. Haagmans, S.H. Al Dhahiry, C.B. Reusken, V.S. Raj, M. Galiano, and R. Myers Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation Lancet Infect Dis 14 2014 140 145
11. M. Khalid, F. Al Rabiah, B. Khan, A. Al Mobeireek, T.S. Butt, and E. Mutairy Ribavirin and interferon (IFN)-α-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases Antivir Ther 2014 10.3851/IMP2792 [Epub ahead of print]
12. D. Falzarano, E. de Wit, A.L. Rasmussen, F. Feldmann, A. Okumura, and D.P. Scott Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques Nat Med 19 2013 1313 1317
13. Schering Corp Product information. REBETOL® (ribavirin, USP). Kenilworth, NJ: Schering Corp. http://archives.who.int/eml/expcom/expcom15/applications/newmed/ribaravin/APP-REBETOL.pdf [accessed 9 September 2014].
14. V.S. Raj, E.A. Farag, C.B. Reusken, M.M. Lamers, S.D. Pas, and J. Voermans Isolation of MERS coronavirus from dromedary camel, Qatar, 2014 Emerg Infect Dis 20 2014 1339 1342
15. World Health Organization. Seroepidemiological investigation of contacts of Middle East respiratory syndrome coronavirus (MERS-CoV) patients. Geneva: Switzerland: WHO; 19 November 2013. http://www.who.int/csr/disease/coronavirus-infections/WHO-Contact-Protocol-MERSCoV-19-November-2013.pdf?ua=1 [accessed 9 September 2014].
16. W. Liu, F. Tang, A. Fontanet, L. Zhan, Q.M. Zhao, and P.H. Zhang Long-term SARS coronavirus excretion from patient cohort, China Emerg Infect Dis 10 2004 1841 1843
17. Y.M. Arabi, A.A. Arifi, H.H. Balkhy, H. Najm, A.S. Aldawood, and A. Ghabashi Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection Ann Intern Med 160 2014 389 397
18. S.K. Lau, C.C. Lau, K.H. Chan, C.P. Li, H. Chen, and D.Y. Jin Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment J Gen Virol 94 2013 2679 2690
19. E. Kindler, H.R. Jónsdóttir, D. Muth, O.J. Hamming, R. Hartmann, and R. Rodriguez Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential MBio 4 2013 e00611 e612
20. B.J. Hart, J. Dyall, E. Postnikova, H. Zhou, J. Kindrachuk, and R.F. Johnson Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays J Gen Virol 95 2014 571 577
21. D. Falzarano, E. de Wit, C. Martellaro, J. Callison, V.J. Munster, and H. Feldmann Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin Sci Rep 3 2013 1686
22. PHE update on MERS-CoV. Public Health England; 14 May 2014. https://www.gov.uk/government/news/phe-update-on-mers-cov [accessed 11 September 2014].
23. I. Eckerle, M.A. Muller, S. Kallies, D.N. Gotthardt, and C. Drosten In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection Virol J 10 2013 359
24. C.M. Chu, V.C. Cheng, I.F. Hung, M.M. Wong, K.H. Chan, and K.S. Chan Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thorax 59 2004 252 256
25. A. Assiri, A. McGeer, T.M. Perl, C.S. Price, A.A. Al Rabeeah, and D.A. Cummings Hospital outbreak of Middle East respiratory syndrome coronavirus N Engl J Med 369 2013 407 416
26. T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, and W.B. Karesh Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia MBio 5 2014 e01146 e1214
27. C.B. Reusken, L. Messadi, A. Feyisa, H. Ularamu, G.J. Godeke, and A. Danmarwa Geographic distribution of MERS coronavirus among dromedary camels, Africa Emerg Infect Dis 20 2014 1370 1374
28. M.G. Hemida, R.A. Perera, P. Wang, M.A. Alhammadi, L.Y. Siu, and M. Li Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013 Euro Surveill 18 2013 20659
29. C.B. Reusken, M. Ababneh, V.S. Raj, B. Meyer, A. Eljarah, and S. Abutarbush Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013 Euro Surveill 18 2013 20662
30. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update - as of 9 May 2014. http://www.who.int/csr/disease/coronavirus-infections/MERS-CoV-Update-09-May-2014.pdf?ua=1 [accessed 14 May 2014].